Replimune Group beat estimated earnings by 7.000000000000001%, reporting an EPS of $-0.77 versus an estimate of $-0.83. Revenue was down $0 from the same period last year. The company missed on EPS by ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in The Trade Desk Inc (Symbol: TTD), where a total of 69,953 contracts have traded so far, ...

Google Gemini has been working on a new “projects” option, much like ChatGPT already offers. Projects will allow you to sort files and chats around particular topics. After recently only finding some ...

We may receive a commission on purchases made from links. When it comes to DIY tech, the Raspberry Pi is one of the most recognizable products out there. It's been around for more than a decade now, ...

The biotech received the good news it was hoping for from a top national regulator. This concerned RP1, its advanced melanoma drug. Well before market open, Replimune announced that the U.S. Food and ...

One of Python’s most persistent limitations is how unnecessarily difficult it is to take a Python program and give it to another user as a self-contained click-to-run package. The design of the Python ...

'The Martian' author Andy Weir leaves the Solar System behind as Ryan Gosling blasts off on a mission to save the world. When you purchase through links on our site, we may earn an affiliate ...

WASHINGTON (AP) — The Trump administration is cancelling $7.6 billion in grants that supported hundreds of clean energy projects in 16 states, all of which voted for Democrat Kamala Harris in last ...

The last time I spoke about Replimune (REPL) it was with respect to a Seeking Alpha article entitled "Replimune: Scope Goes Beyond That of RP1 Oncolytic Targeting For Melanoma." With respect to this ...

Following a ~39% drop in the previous session, Replimune (NASDAQ:REPL) shares continued to trade lower on Friday as J.P. Morgan downgraded the stock to Underweight from Neutral, citing further ...